Cryo-Cell International, Inc.
CCEL
Rank in Stocks
#23646
Cryo-Cell International, Inc. engages in cord blood and cord tissue... Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Share Price
$4.99
Last synced: 2026-11-09
Market Cap
$40.23M
Change (1 day)
2.04%
Change (1 year)
23.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cryo-Cell International, Inc. (CCEL)
Category
Healthcare
EPS for Cryo-Cell International, Inc. (CCEL)
EPS as of August 2026 TTM: $-0.22
According to Cryo-Cell International, Inc.'s latest financial reports, its current EPS (TTM) is $-0.22. At the end of 2025 the company had an EPS of $-0.30, a decrease compared to its 2024 EPS of $0.05.
EPS history for Cryo-Cell International, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.22 | -26.67% |
| 2025 | $-0.30 | -700.00% |
| 2024 | $0.05 | -104.39% |
| 2023 | $-1.14 | -445.45% |
| 2022 | $0.33 | 26.92% |
| 2021 | $0.26 | -45.83% |
| 2020 | $0.48 | 65.52% |
| 2019 | $0.29 | -363.64% |
| 2018 | $-0.11 | -133.33% |
| 2017 | $0.33 | -306.25% |
| 2016 | $-0.16 | -118.82% |
| 2015 | $0.85 | 1,600.00% |
| 2014 | $0.05 | 1,900.00% |
| 2013 | 0.00 | -100.45% |
| 2012 | $-0.56 | 211.11% |
| 2011 | $-0.18 | -162.07% |
| 2010 | $0.29 | 141.67% |
| 2009 | $0.12 | -284.90% |
| 2008 | $-0.06 | -84.91% |
| 2007 | $-0.43 | 79.17% |
| 2006 | $-0.24 | -366.67% |
| 2005 | $0.09 | -64.00% |
| 2004 | $0.25 | -137.88% |
| 2003 | $-0.66 | 40.43% |
| 2002 | $-0.47 | -622.22% |
| 2001 | $0.09 | -160.00% |
| 2000 | $-0.15 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.27 | -13,859.09% |
US
|
|
| $3.19 | -1,549.73% |
DE
|
|
| $34.71 | -15,877.27% |
US
|
|
| $1.90 | -964.64% |
SA
|
|
| $0.29 | -230.91% |
CN
|
Questions about Cryo-Cell International, Inc.'s earnings per share (EPS)
What is Cryo-Cell International, Inc.'s earnings per share (EPS)?
Cryo-Cell International, Inc.'s earnings per share (EPS) over the last twelve months is $-0.22, as of Aug 2026.
What was Cryo-Cell International, Inc.'s earnings per share (EPS) in 2025?
In 2025, Cryo-Cell International, Inc.'s earnings per share (EPS) was $-0.30, compared with $0.05 in 2024.
How has Cryo-Cell International, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cryo-Cell International, Inc.'s earnings per share (EPS) was highest in 2020 ($0.48) and lowest in 2023 ($-1.14).
How does Cryo-Cell International, Inc.'s earnings per share (EPS) compare with similar companies?
Cryo-Cell International, Inc.'s earnings per share (EPS) ($-0.22) is lower than that of all 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.